Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Demographical Profile and Clinical Outcomes of Covid-19 Patients at a Tertiary Care Centre

Jain et al., Journal of Cardiovascular Disease Research, doi:10.31838/jcdr.2023.14.05.215
May 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments. c19early.org
Retrospective 100 COVID-19 patients in India, showing higher vitamin D levels associated with survival and lower severity in unadjusted results.
Jain et al., 31 May 2023, retrospective, India, peer-reviewed, 4 authors.
This PaperVitamin DAll
Demographical Profile and Clinical Outcomes of Covid-19 Patients at a Tertiary Care Centre
Dr Samyak Jain, V K Singh, Sapna Yadav, Achintya Agrawal
Background: A new strain of coronavirus responsible for pneumonia of unknown origin was detected in early January 2020, named as 2019-novel coronavirus. Even though COVID-19 has affected all regions of the world, there are great variations in the prevalence of the disease and mortality rates in different countries, the reasons for which are poorly understood. In this study, we analysed the clinical manifestation, laboratory profile and final outcome in COVID-19 patients in our Medical College & Hospital providing tertiary care with the purpose of adding information to the already existing data. Material and Methods: Inclusion Criteria: All positive and confirmed cases of COVID-19 disease, admitted in COVID wards, HDU, ICU of our Medical College & Hospital, irrespective of age & gender. Results: Majority of study subjects (61%) were above 40 years of age. The commonest presenting complaint was cough with less than one-fifth having fever. Sputum was present in 27% of cases and more common in live subjects. Breathlessness was present in 56% of cases and more common in expired subjects. Oxygen support was required in 59% of cases. Treatment with Remdesivir was needed in more than 80% of non-survivors of Covid-19 disease while less than 30% survivors needed Remdesivir therapy. Plasma treatment therapy was given in 6% and Mechanical ventilation in 34% of cases. Conclusion: Majority of the patients were asymptomatic but potential spreaders of the disease. Fever, cough, and breathlessness were the major presenting symptoms. Advanced age, high TLC with high N/L ratio, high CRP level, high serum ferritin level, high D-dimer value and low vitamin D levels correlated positively with severity of disease responsible for high mortality rate.
References
Dosi, Jain, Mehta, Clinical Characteristics, Comorbidities,and Outcome among 365 Patients of Coronavirus Disease 2019 at a Tertiary Care Centre in Central India, J Assoc Physicians India
Mohan, Tiwari, Bhatnagar, Patel, Maurya et al., Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India, Indian J Med Res
Panda, Bandyopadhyay, Singh, Moirangthem, Chikara et al., Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection -a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial, Trials
Prakash, Agrawal, Kumar, Yadav, Clinical and epidemiological profile of patients infected by COVID-19 at a tertiary care centre in North India. Monaldi Arch Chest Dis
Singla, Gowda, Mohindra, Suri, Dhibar et al., Clinical spectrum and outcome of patients visiting coronavirus screening centre in North India and clinical predictors for COVID-19, J Family Med Prim Care
Soni, Kajal, Yaddanapudi, Malhotra, Puri et al., Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India, Indian J Med Res
Suleyman, Fadel, Malette, Hammond, Abdulla et al., Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit, JAMA Netw Open
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit